Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of the National Cancer Institute

• Publication date

  2000-02-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNCI/92.4.313PMID 10675380
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular genetic studies of early breast cancer evolution

  2004cited by this paper
• Predictors of local recurrence following excision alone for ductal carcinoma in situ

  1999cited by this paper
• Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.

  1999cited by this paper
• The influence of margin width on local control of ductal carcinoma in situ of the breast.

  1999influential reference
• Predictors of local recurrence after treatment of ductal carcinoma in situ - A meta-analysis

  1999cited by this paper
• Genome-wide analysis of DNA copy-number changes using cDNA microarrays

  1999cited by this paper
• Predicting the likelihood of residual disease in women treated for ductal carcinoma in situ.

  1999cited by this paper
• Comparison of loss heterozygosity in primary and recurrent ductal carcinoma in situ of the breast.

  1998cited by this paper
• Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast.

  1998cited by this paper
• Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.

  1998cited by this paper
• Risk of recurrence after ductal carcinoma in situ of the breast.

  1998cited by this paper
• Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast.

  1998cited by this paper
• The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ.

  1998cited by this paper
• Genetic alterations in primary bladder cancers and their metastases.

  1998cited by this paper
• Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma

  1997cited by this paper
• Genetic alterations in primary breast cancers and their metastases: Direct comparison using modified comparative genomic hybridization

  1997cited by this paper
• Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.

  1997cited by this paper
• Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS).

  1997cited by this paper
• Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer.

  1997cited by this paper
• Chromosomal alterations in ulcerative colitis-related neoplastic progression.

  1997cited by this paper
• The Results of Conservative Surgery and Radiation for Mammographically Detected Ductal Carcinoma In Situ

  1997cited by this paper
• Incidence of and treatment for ductal carcinoma in situ of the breast.

  1996cited by this paper
• Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.

  1996cited by this paper
• Genetic divergence in the clonal evolution of breast cancer.

  1996cited by this paper
• Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy.

  1995cited by this paper
• Comparative Genomic Hybridization

  1995cited by this paper
• Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.

  1995cited by this paper
• Heterogeneity of duct carcinoma in situ (DCIS): relationship of grade and subtype analysis to local recurrence and risk of invasive transformation.

  1995cited by this paper
• Influence of local treatment on the recurrence rate of ductal carcinoma in situ.

  1995cited by this paper
• Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast.

  1995cited by this paper
• Allelic loss and the progression of breast cancer.

  1995cited by this paper
• Computer image analysis of comparative genomic hybridization.

  1995cited by this paper
• Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.

  1995cited by this paper
• Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.

  1995cited by this paper
• Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas.

  1995cited by this paper
• Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.

  1995cited by this paper
• Tumors of the Mammary Gland

  1994cited by this paper
• p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.

  1994cited by this paper
• Current protocols in human genetics

  1994cited by this paper
• Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer.

  1993cited by this paper
• Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

  1992cited by this paper

• Single-Cell Expression Analysis of Ductal Carcinoma In Situ Identifies Complex Genotypic–Phenotypic Relationships Altering Epithelial Composition

  2025cites this paper
• Single Cell Expression Analysis of Ductal Carcinoma in Situ Identifies Complex Genotypic-Phenotypic Relationships Altering Epithelial Composition

  2024cites this paper
• Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance

  2024cites this paper
• Local recurrence of submucosal invasive colorectal cancer after endoscopic submucosal dissection revealed by copy number variation

  2023cites this paper
• Archival single-cell genomics reveals persistent subclones during DCIS progression.

  2023cites this paper
• The double agents in liquid biopsy: promoter and informant biomarkers of early metastases in breast cancer

  2022cites this paper
• Whole genome sequencing of hematologically stained cells catapulted from Cell smears

  2022cites this paper
• Evaluating statistical approaches to define clonal origin of tumours using bulk DNA sequencing: context is everything

  2022cites this paper
• The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ

  2021cites this paper
• Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast

  2021cites this paper
• Local Recurrence after Treatment of Ductal Carcinoma In Situ: A Comprehensive Overview.

  2021cites this paper
• Cancer stem cells and combination therapies to eradicate them.

  2020cites this paper
• Transcriptome and genome evolution during HER2-amplified breast neoplasia

  2020cites this paper
• Tumour evolution and novel biomarkers in breast cancer

  2019cites this paper
• Prognostic role of immune infiltrates in breast ductal carcinoma in situ

  2019cites this paper
• A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast

  2019cites this paper
• INVESTIGATING INVASION IN DUCTAL CARCINOMA IN SITU WITH TOPOGRAPHICAL SINGLE CELL GENOME SEQUENCING

  2018cites this paper
• Clonal relatedness in tumour pairs of breast cancer patients

  2018cites this paper
• DCIS: The Problem of Recurrence

  2018cites this paper
• Modulation of oncogenic transcription factors by bioactive natural products in breast cancer

  2017cites this paper
• Genome evolution in ductal carcinoma in situ: invasion of the clones

  2017cites this paper
• Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis

  2017cites this paper
• Deciphering the molecular signaling pathways in breast cancer pathogenesis and their role in diagnostic and treatment modalities

  2017cites this paper
• The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis

  2016cites this paper
• Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis

  2016cites this paper
• Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma

  2016cites this paper
• Catalog of genetic progression of human cancers: breast cancer

  2016cites this paper
• Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community

  2016cites this paper
• Systems Biology of Cancer: Genomic instability and carcinogenesis

  2015cites this paper
• Pathology of Ductal Carcinoma In Situ: Features and Diagnostic Challenges

  2015cites this paper
• Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis

  2015cites this paper
• [Surgical treatment of soft tissue sarcomas].

  2015cites this paper
• Copy number analysis of ductal carcinoma in situ with and without recurrence

  2015cites this paper
• Tumor dormancy and cancer stem cells: two sides of the same coin?

  2013cites this paper
• A diagnostic algorithm to identify paired tumors with clonal origin

  2013influential citation
• Early Telomere Shortening and Genomic Instability in Tubo-Ovarian Preneoplastic Lesions

  2013cites this paper
• Karzinogenese der Mammakarzinome

  2013cites this paper
• Graph- and kernel-based integrative analyses of multi-layers of heterogeneous genomic data

  2013cites this paper
• Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients.

  2013cites this paper
• Cell fusion in tumor development: accelerated genetic evolution.

  2013cites this paper
• Chemokines fluctuate in the progression of primary breast cancer.

  2013cites this paper
• Phase I trial of intraoperative detection of tumor margins in patients with HER2-positive carcinoma of the breast following administration of 111In-DTPA-trastuzumab Fab fragments.

  2013cites this paper
• Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma

  2012cites this paper
• Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma

  2012cites this paper
• Title : Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients

  2012cites this paper
• Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ

  2012cites this paper
• Immortalization and malignant transformation of Eukaryotic cells

  2012cites this paper
• Clinical and molecular analysis of synchronous double lung cancers.

  2012cites this paper
• Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer

  2012cites this paper
• Ductal Carcinoma In Situ

  2012cites this paper
• Synergistic effect of different levels of genomic data for cancer clinical outcome prediction

  2012cites this paper
• Caractérisation de marqueurs moléculaires associés à un haut risque de développement de métastases chez des patients atteints du mélanome de la choroïde

  2011cites this paper
• Chapter 27 -- Breast Cancer Genomics, Section VI, Pathology and Biological Markers of Invasive Breast Cancer

  2011cites this paper
• Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ

  2011cites this paper
• Breast: Ductal Carcinoma In Situ (DCIS)

  2011cites this paper
• Array-based Comparative Genomic Hybridization and Its Application to Cancer Genomes and Human Genetics

  2011cites this paper
• Biologic characteristics of premalignant breast disease

  2011cites this paper
• The Progression of Pre-invasive to Invasive Cancer

  2011cites this paper
• A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data

  2010influential citation
• Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation

  2010cites this paper
• Novel Xenograft and Cell Line Derived From an Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas Give New Insights Into Molecular Mechanisms

  2010cites this paper
• Preinvasive breast cancer.

  2010cites this paper
• Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma.

  2010cites this paper
• Current perspectives of treatment of ductal carcinoma in situ.

  2010cites this paper
• Testing Clonal Relatedness of Tumors Using Array Comparative Genomic Hybridization: A Statistical Challenge

  2010cites this paper
• Breast cancer precursors: lessons learned from molecular genetics

  2009cites this paper
• Genomic and Mutational Profiling to Assess Clonal Relationships Between Multiple Non–Small Cell Lung Cancers

  2009cites this paper
• Ipsilateral Breast Tumor Recurrence

  2009cites this paper
• Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma

  2009cites this paper
• Genomic profiling of breast cancer

  2009cites this paper
• The role of molecular analysis in breast cancer

  2009cites this paper
• Transition A Human Breast Cell Model of Preinvasive to Invasive

  2008cites this paper
• High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers.

  2008cites this paper
• A human breast cell model of preinvasive to invasive transition.

  2008cites this paper
• Perilobar Nephrogenic Rests Are Nonobligate Molecular Genetic Precursor Lesions of Insulin-Like Growth Factor-II-Associated Wilms Tumors

  2008cites this paper
• Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast

  2008cites this paper
• Ipsilateral breast cancer recurrence.

  2008cites this paper
• Genomic Differences Between Pure Ductal Carcinoma In Situ of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study

  2008cites this paper
• Breast-conserving therapy for ductal carcinoma in situ Bijker

  2008cites this paper
• The hTERT mRNA in plasma samples of early breast cancer patients, non-cancer patients and healthy individuals.

  2008cites this paper
• Insight into estrogen action in breast cancer via the study of a novel nuclear receptor corepressor: SLIRP

  2008cites this paper
• Characterization of breast cancer by array comparative genomic hybridization.

  2007cites this paper
• Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors.

  2007cites this paper
• Genetic Heterogeneity in Patients with Multiple Neoplastic Lung Lesions: A Report of Three Cases

  2007cites this paper
• Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases

  2007cites this paper
• Evaluation of tumor suppressor gene p53, oncogene c-erbB-2 and matrix-metalloproteinase-9 as prognostic and predictive factors in breast carcinoma

  2007cites this paper
• Are ipsilateral breast tumour invasive recurrences in young (⩽40 years) women more aggressive than their primary tumours?

  2007cites this paper
• Evaluation of Mammography Performance in the United States: The Breast Cancer Surveillance Consortium

  2007cites this paper
• HRPAP20 : a novel calmodulin-binding phosphoprotein involved in tumor progression.

  2007cites this paper
• Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.

  2007cites this paper
• Evidence of a Genomic Biomarker in Normal Human Epithelial Mammary Cell Line, MCF-10A, That Is Absent in the Human Breast Cancer Cell Line, MCF-7

  2006cites this paper
• Clinical presentation and surgical quality in treatment of ductal carcinoma in situ of the breast

  2006cites this paper
• Ductal Carcinoma In Situ: a Modern Approach to Patient Management

  2006cites this paper
• DCIS: Pathology and Molecular Markers

  2006cites this paper
• Applying the neoadjuvant paradigm to ductal carcinoma in situ

  2006cites this paper
• Array-CGH and breast cancer

  2006cites this paper
• Molecular basis of breast cancer.

  2006cites this paper
• Review Array-CGH and breast cancer

  2006cites this paper
• Local Recurrences After Conservative Treatment of Ductal Carcinoma-In-Situ of the Breast Without Radiotherapy: The Effect of Age

  2006cites this paper
• Ploidy status rarely changes in myeloma patients at disease progression.

  2006cites this paper